The University of Chicago Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Russell R. Reid and Hue H. Luu.
Connection Strength

0.989
  1. The wonders of BMP9: From mesenchymal stem cell differentiation, angiogenesis, neurogenesis, tumorigenesis, and metabolism to regenerative medicine. Genes Dis. 2019 Sep; 6(3):201-223.
    View in: PubMed
    Score: 0.178
  2. The inhibition of BRAF activity sensitizes chemoresistant human ovarian cancer cells to paclitaxel-induced cytotoxicity and tumor growth inhibition. Am J Transl Res. 2020; 12(12):8084-8098.
    View in: PubMed
    Score: 0.049
  3. Blockade of IGF/IGF-1R signaling axis with soluble IGF-1R mutants suppresses the cell proliferation and tumor growth of human osteosarcoma. Am J Cancer Res. 2020; 10(10):3248-3266.
    View in: PubMed
    Score: 0.048
  4. Transcriptomic landscape regulated by the 14 types of bone morphogenetic proteins (BMPs) in lineage commitment and differentiation of mesenchymal stem cells (MSCs). Genes Dis. 2019 Sep; 6(3):258-275.
    View in: PubMed
    Score: 0.044
  5. BMP9-induced osteoblastic differentiation requires functional Notch signaling in mesenchymal stem cells. Lab Invest. 2019 01; 99(1):58-71.
    View in: PubMed
    Score: 0.042
  6. A Simplified System to Express Circularized Inhibitors of miRNA for Stable and Potent Suppression of miRNA Functions. Mol Ther Nucleic Acids. 2018 Dec 07; 13:556-567.
    View in: PubMed
    Score: 0.042
  7. Reversibly immortalized human umbilical cord-derived mesenchymal stem cells (UC-MSCs) are responsive to BMP9-induced osteogenic and adipogenic differentiation. J Cell Biochem. 2018 11; 119(11):8872-8886.
    View in: PubMed
    Score: 0.042
  8. Characterization of the essential role of bone morphogenetic protein 9 (BMP9) in osteogenic differentiation of mesenchymal stem cells (MSCs) through RNA interference. Genes Dis. 2018 Jun; 5(2):172-184.
    View in: PubMed
    Score: 0.041
  9. The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs. Genes Dis. 2018 Mar; 5(1):62-74.
    View in: PubMed
    Score: 0.040
  10. CRISPR/Cas9-mediated reversibly immortalized mouse bone marrow stromal stem cells (BMSCs) retain multipotent features of mesenchymal stem cells (MSCs). Oncotarget. 2017 Dec 19; 8(67):111847-111865.
    View in: PubMed
    Score: 0.040
  11. lncRNA H19 mediates BMP9-induced osteogenic differentiation of mesenchymal stem cells (MSCs) through Notch signaling. Oncotarget. 2017 Aug 08; 8(32):53581-53601.
    View in: PubMed
    Score: 0.039
  12. Notch Signaling Augments BMP9-Induced Bone Formation by Promoting the Osteogenesis-Angiogenesis Coupling Process in Mesenchymal Stem Cells (MSCs). Cell Physiol Biochem. 2017; 41(5):1905-1923.
    View in: PubMed
    Score: 0.038
  13. Sustained high level transgene expression in mammalian cells mediated by the optimized piggyBac transposon system. Genes Dis. 2015 Mar; 2(1):96-105.
    View in: PubMed
    Score: 0.033
  14. A simplified and versatile system for the simultaneous expression of multiple siRNAs in mammalian cells using Gibson DNA Assembly. PLoS One. 2014; 9(11):e113064.
    View in: PubMed
    Score: 0.032
  15. Conditionally immortalized mouse embryonic fibroblasts retain proliferative activity without compromising multipotent differentiation potential. PLoS One. 2012; 7(2):e32428.
    View in: PubMed
    Score: 0.027
  16. Epigenetic regulation of mesenchymal stem cells: a focus on osteogenic and adipogenic differentiation. Stem Cells Int. 2011; 2011:201371.
    View in: PubMed
    Score: 0.026
  17. BMP-9 induced osteogenic differentiation of mesenchymal stem cells: molecular mechanism and therapeutic potential. Curr Gene Ther. 2011 Jun; 11(3):229-40.
    View in: PubMed
    Score: 0.025
  18. The therapeutic potential of the Wnt signaling pathway in bone disorders. Curr Mol Pharmacol. 2011 Jan; 4(1):14-25.
    View in: PubMed
    Score: 0.025
  19. Mesenchymal Progenitor Cells and Their Orthopedic Applications: Forging a Path towards Clinical Trials. Stem Cells Int. 2010 Dec 16; 2010:519028.
    View in: PubMed
    Score: 0.025
  20. Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res. 2010 Nov; 25(11):2447-59.
    View in: PubMed
    Score: 0.024
  21. Mesenchymal stem cells: Molecular characteristics and clinical applications. World J Stem Cells. 2010 Aug 26; 2(4):67-80.
    View in: PubMed
    Score: 0.024
  22. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev. 2009 May; 18(4):545-59.
    View in: PubMed
    Score: 0.022
  23. Hey1 basic helix-loop-helix protein plays an important role in mediating BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. J Biol Chem. 2009 Jan 02; 284(1):649-659.
    View in: PubMed
    Score: 0.021
  24. BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling. J Cell Mol Med. 2009 Aug; 13(8B):2448-2464.
    View in: PubMed
    Score: 0.021
  25. Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects. Lab Invest. 2008 Dec; 88(12):1264-77.
    View in: PubMed
    Score: 0.021
  26. Regulation of osteogenic differentiation during skeletal development. Front Biosci. 2008 Jan 01; 13:2001-21.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.